Helping to close the loop on glycaemic control
A patient’s experience of evolving technology for type 1 diabetes management highlights the gains such devices can help achieve in control and quality of life
Kaye is a 60-year-old woman with a highly demanding job as a CEO.
She was diagnosed with type 1 diabetes at age 54 and started on basal insulin glargine and bolus insulin aspart.
Kaye uses a bolus calculator to determine meal doses and is diligent about administering insulin at breakfast and lunch.
She is less likely to bolus for the evening meal, attributing this to exhaustion and fear of overnight hypoglycaemia.
